News
-
-
-
-
-
PRESS RELEASE
M1 Kliniken AG reports strong EBIT Growth of 11% and achieves Earnings per Share of EUR 0.86.
M1 Kliniken AG reports strong EBIT growth of 11% and achieves earnings per share of EUR 0.86 in the first nine months of 2025, with key financials showing positive trends in revenue and profitability -
-
-
-
-
PRESS RELEASE
A natural breakthrough in protecting cereals and field crops // Syngenta and Amoeba SA to develop and commercialize biocontrol solutions for EU and UK
Syngenta and Amoéba partner to develop bio-fungicide for cereals, combating fungal diseases. Planned agreement aims to enhance biological crop protection and sustainability in EU and UK markets